NCT03721874 - Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

June 29, 2021

Study Completion Date

June 29, 2021

Conditions

Prediabetic StateSubstrate Oxidation

Interventions

DRUG

Dapagliflozin 10mg

"The study consist of 2 weeks treatment period 1, 6-8 weeks wash-out period and 2 weeks treatment period 2.~The subject may be administered dapagliflozin 10 mg during Period 1 or Period 2."

DRUG

Placebo matching to Dapagliflozin 10 mg

"The study consist of 2 weeks treatment period 1, 6-8 weeks wash-out period and 2 weeks treatment period 2.~The subject may be administered placebo during Period 1 or Period 2."

Trial Locations (1)

6200 MD

Maastricht University and Medical Centre, Maastricht